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Objectives. We assessed the impact of transthoracic endoscopic sympathectomy (TES) on the quality of life of patients with
palmar hyperhydrosis.
Design. A retrospective questionnaire based study.
Methods. Patients undergoing TES at our institution between 1997 and 2002 received a SF-36 quality of life postal
questionnaire. The pre- and post-operative symptoms were assessed. Statistical analysis was by means of the Student’s t test.
Results. Ninety-four TES were carried out in 62 patients. Forty-one cases were female. The age range was 17–64 years. The
mean follow-up period was 38.46 months. Mean hospital stay was 3 days. Compensatory hyperhydrosis was reported in 29
cases and only considered severe in four cases (9.7%). Forty-one patients replied to the questionnaire (66%). The overall
quality of life (as assessed by the SF-36 form) was unanimously improved (p , 0.0009) and demonstrated significant
improvements in social functioning (p , 0.0002), physical role limitations (p , 0.0007), emotional well-being
(p , 0.0007) and overall energy levels (p , 0.05).
Conclusion. TES resulted in significant improvements inpatient’s overall quality of life, social and emotional functioning.
The procedure is associated with minimal morbidity and only a short inpatient stay is required. Patients should be cautioned
on the possibility of compensatory hyperhydrosis which may occur in a small number of cases.
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Introduction
Hyperhydrosis is a benign but extremely socially
disabling condition with an estimated prevalence of
1% in the western world.1 Primary hyperhydrosis
lacks a precise definition, but can be described as a
condition of excess perspiration of the eccrine glands
innervated by cholinergic fibres from the sympathetic
nervous system. Excessive perspiration is accentuated
by mental stimuli rather than heat and exercise,
although studies have not reported affected patients
to be unduly neurotic or nervous.2 The gold standard
for treatment of palmar hyperhydrosis has long been
recognized as thoracic sympathectomy3 Though orig-
inally carried out as an open procedure, a minimally
invasive thoracoscopic approach is now used. The
effects are usually instantaneous, with patients leaving
hospital with dry palms within 24 h. The impact of this
surgery on the patient’s lifestyle has only been
addressed in a very small number of studies to
date.4 – 6 Furthermore, the use of a validated quality
of life questionnaire for this purpose has not been
consistently applied. Our own practice has used this
surgical technique in almost 100 operative cases in the
past five years, however, the success of the procedure
has not been critically evaluated to date.
Methods
This was a retrospective, questionnaire-based study.
Patients who underwent transthoracic endoscopic
sympathectomy (TES) at our institution over the
preceding five years were identified via the hospital
inpatient coding system (HIPE) and from theatre
records. Patient records were then accessed to assess
demographics, inpatient operative management and
detectable morbidity. The surgical approach of TES in
our unit uses diathermy ablation of the sympathectic
nerve chain, and ganglia over the bodies of the second
and third thoracic vertebrae (T2 and T3). We specifi-
cally avoid diathermy higher than T2 and do not
attempt to target nerves below T3. We also never
undertake the bilateral sympathectomy in one operat-
ive sitting. Effective disruption of the sympathectic
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nerve chain is completed with extension of the
diathermy ablation from the body of the thoracic
vertebra to 2 cm laterally along the neck of the adjacent
rib. A standardized and validated quality of life
questionnaire (SF-36) was posted to all patients with
accompanying instructions to document their pre and
post operative symptoms in relation to eight scoring
scales. Data collection was by a combination of postal
questionnaire and clinical interview. Statistical anal-
ysis was by means of the Student’s t test.
Results
Ninety-four TES were carried out in 62 patients, of
whom 41 were female and 21 male. Thirty-one patients
had bilateral procedures and one patient necessitated
a repeat unilateral procedure. The patient age range
was from 17 to 64 years, with a mean age of 29 years.
The follow-up period ranged from three to 75 months,
with a mean of 38.46 months. Mean hospital stay was
three days (range 1–9).
There was no significant morbidity encountered,
specifically no evidence of a Horner’s syndrome and
no blood transfusions were required. One patient had
unilateral recurrence of symptoms, which resolved
with a repeat procedure. Compensatory hyperhydro-
sis was the most common side-effect encountered,
being reported in 29 cases, however, this was only
described as severe in four cases (9.7%).
Forty-one of the 62 patients replied to the ques-
tionnaire (66%). There was no difference in the
percentage of male responders and female responders
with the corresponding response rates being 65 and
66%, respectively. The majority of patients that
responded to the SF-36 questionnaire had undergone
a bilateral procedure (59%). In males undergoing a
unilateral procedure 82% replied whereas only 40% of
females replied. In those patients that underwent a
bilateral procedure then this trend was reversed with
91% of females replying and only 44% of males
replying. In those who responded, the overall quality
of life as assessed by the SF-36 was unanimously
improved ðp , 0:0009Þ (Table 1). The SF-36 form also
demonstrated a statistically significant improvement
in social functioning ðp , 0:0002Þ; physical role limi-
tations ðp , 0:0007Þ; emotional well-being ðp , 0:0007Þ
and overall energy levels ðp , 0:05Þ: There was an
expected increase in bodily pain reported at the time of
surgery ðp , 0:001Þ: We also examined our results on
the basis of unilateral versus bilateral procedures.
Those patients that underwent a bilateral procedure
reported further statistical improvements in nearly all
the outcome parameters assessed by the SF-36 form. Ta
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These included further improvements in both ‘physi-
cal functioning’ ðp , 0:01Þ; and ‘emotional role limi-
tations’ ðp , 0:04Þ: Those patients that underwent a
unilateral procedure did not demonstrate this statisti-
cal improvement.
Discussion
Current treatment options for palmar hyperhydrosis
include topical aluminium chloride, direct current and
even iontophoresis.7 – 9 All these approaches suffer
from a transient success rate and the necessity of
reapplication. Significant success has been reported
using Botulinum toxin injections.10 – 12 However, pro-
blems include pain at the site of administration, lack of
consensus with regard to method and dosage and the
temporary nature of the results (4–7 months).13
Endoscopic ablation of sympathetic ganglia was first
described in 1949 and differing operative approaches
include access through the second or the fourth
intercostal space in the mid-axillary line.14,15 Compli-
cations reported with trans-axillary approaches
include pneumonia (4%), infection (3%), Horner’s
syndrome (3%) and injury to the long thoracic nerve.
The most common side-effect quoted is compensatory
sweating affecting the trunk and lower extremities (5–
74%). Nearly all patients in our experience described
this as a minor nuisance compared with their original
complaint and as a rule this improves with time.16,17
Our study was a retrospective assessment of the
quality of life in patients undergoing surgery for the
non-life threatening condition of hyperhydrosis.
Despite our data not being undertaken in a prospec-
tive study design format the core message from the
data was clear. TES had a significant impact on the
quality of life of patients with palmar hyperhydrosis.
Significant improvements in patient’s ‘physical role
limitations’, ‘emotional well being’, ‘energy’ and
‘social functioning’ using the SF-36 quality of life
questionnaire were demonstrated. Most importantly,
patients recorded an overall significant improvement
in their ‘overall quality of life’ ðp , 0:001Þ:
Sixty-two patients underwent surgery. Thirty-one
patients underwent bilateral surgery. Forty-one
patients replied to the to the SF-36 questionnaire
(66%). Twenty-four of those that had bilateral pro-
cedures (77%) replied, whereas, only 17 of those that
had unilateral surgery performed replied (55%). When
one assessed the number of responders on the basis of
sex distribution there was no difference found.
Interestingly however, the majority of patients pro-
ceeding on to have bilateral procedures were female. It
would seem inherently sensible that in those patients
that proceeded on to have the contralateral side
operated upon then they would have been happy
with the their initial outcome from the original side.
This is reflected in the statistical analysis of unilateral
versus bilateral responders with patients undergoing a
bilateral procedure demonstrating further statistical
improvements in the SF-36 outcome parameters
assessed. Although, a number of those patients that
have only undergone unilateral surgery are scheduled
to undergo surgery on the contralateral side this bias
in the responders may account for some of these study
findings.
Problems with this study included patients report-
ing the SF-36 too general a questionnaire with certain
questions seeming irrelevant given the condition
being assessed. This fact serves to highlight the need
for a quality of life questionnaire to be developed and
tested with the specific needs and symptoms of the
patient with hyperhydrosis in mind. The definite
benefits of improved overall quality of life and both
social and emotional functioning are, however, con-
firmed by this study. In our experience, the procedure
is associated with minimal associated morbidity and
only a short inpatient stay is required. Patients should,
however, be cautioned on the possibility of compen-
satory hyperhydrosis which may occur in a small
number of cases.
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